Immunohistochemistry (IHC) Market Global Research and In-Depth Analysis 2021-2026

The global Immunohistochemistry (IHC) market gives essential information, objective insights regarding global market top key players analysis, and much more. The report provides detailed information on segmentation which covers product type, various components, end-user or applications, and various regions. The report deals with the most driving forces influencing the market’s revenue scale. The report delivers a comprehensive analysis of key segments, recent trends, major drivers, growth constraints, competitive landscape during this market. The impact of the COVID-19, and also forecasts its recovery post-COVID-19. The report also presents forecasts for Immunohistochemistry (IHC) investments from 2021 till 2026.

The global Immunohistochemistry (IHC) market size was valued at USD 2.3 billion in 2020 and is expected to grow at a CAGR of 8.1% over the forecast period.

Click Here to Get Free Sample PDF Copy of Latest Research on Immunohistochemistry (IHC) Market 2021 Before Purchase:

https://www.marketinsightsreports.com/reports/04192798517/immunohistochemistry-ihc-market-insights-competitive-landscape-and-market-forecast2026/inquiry?Mode=18

Market Overview: -

Immunohistochemistry is a method that involves the identification of specific antigens within the tissues after using an antigen-specific antibody. Detection and visualization at microscopic levels can be performed via labeling the antibody with a substance that can be visualized, it can be done either with the help of conjugation to a fluorescent marker or the enzymes that can be followed by the method of colorimetric detection. It is a potential microscopy-based technique and can be used to visualize components such as proteins or other types of macromolecules in tissue samples. The invention of the IHC technique was done in the 1940s. It is also used widely in the diagnosis of diseases by specific tumor markers which can easily aid in the determination of the origin of the tumor and the grade of tumor cells, in the identification of the cell type and classification of the tumor.

The prominent players in the Global Immunohistochemistry (IHC) Market:

Hoffmann-LA Roche AG, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck KGaA, Abcam PLC, Bio-Rad Laboratories, Inc., Perkinelmer, Inc., Cell Signaling Technology, Inc., Bio SB, and Others.

Industry News: -

Agilent Receives Expanded FDA Approval for PD-L1 IHC 22C3 pharmDx in Triple-Negative Breast Cancer

Agilent Technologies Inc. (NYSE: A) today announced it has received FDA approval for the utilization of PD-L1 IHC 22C3 pharmDx as an aid in identifying patients with triple-negative breast cancer (TNBC) for treatment with KEYTRUDA (pembrolizumab).

PD-L1 expression may be a critical biomarker for response to anti-PD-1 therapies like KEYTRUDA. The expanded use of PD-L1 IHC 22C3 pharmDx strengthens the power of pathologists to spot patients who could also be eligible for treatment with KEYTRUDA. KEYTRUDA, together with chemotherapy, is approved for patients with locally recurrent unresectable or metastatic TNBC whose tumors express PD-L1 [Combined Positive Score (CPS) ≥ 10] as determined by an FDA-approved test.

Based on Product Types, The Immunohistochemistry (IHC) Market is segmented into:

Antibodies
Reagents
Chromogenic Substrates
Histological Stains
Blocking Sera & reagents
Fixation reagents
Stabilizers
Organic Solvents
Proteolytic Enzymes
Diluents
Equipment & kits

Based on Application, The Immunohistochemistry (IHC) Market is segmented into:

Diagnostic
Cancer
Infectious diseases
Cardiovascular diseases
Autoimmune diseases
Diabetes mellitus
Nephrological diseases
Research & forensic

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), and market share and growth rate of Immunohistochemistry (IHC) Market these regions, from 2021 to 2026 (forecast), covering North America, Europe, China, Japan, Southeast Asia, India, North America (USA, Canada, and Mexico) Europe (Germany, France, UK, Russia, and Italy) Asia–Pacific (China, Japan, Korea, India, and Southeast).

Significant Features that are under Offering and Key Highlights of the Reports:

– Detailed overview of Immunohistochemistry (IHC) Market
– Changing market dynamics of the industry
– In-depth market segmentation by Type, Application, etc.
– Historical, Current, and projected market size in terms of volume and value
– Recent industry trends and developments
– Competitive landscape of Immunohistochemistry (IHC) Market
– Strategies of key players and product offerings
– Potential and niche segments/regions exhibiting promising growth

Click the link to Browse This Full Report @:

https://www.marketinsightsreports.com/reports/04192798517/immunohistochemistry-ihc-market-insights-competitive-landscape-and-market-forecast2026?Mode=18

Other Value additions available with the standard report:

We can also provide the following additional customization and information at an additional cost and delivery time:

1- A detailed country-wise market share analysis of the various companies and their brands.
2- We can also provide a country-wise analysis of the market for more specific market segments.
3- We can also provide a detailed pipeline report for the devices and related drugs for a better understanding of the market.

Please Note: All the above points come under additional customization and the costs can be confirmed with our sales team: sales@marketinsightsreports.com

Contact Us:

Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: +1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com
irfan@marketinsightsreports.com

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and Chinese and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.